A commissioning procedure for breast intracavitary electronic brachytherapy systems

Journal of Applied Clinical Medical Physics

Volumn 9, Issue 3, 2008, Pages 58-68

  Hiatt, Jessica R ^a   Cardarelli, Gene ^a   Hepel, Jaroslaw ^a   Wazer, David ^a   Sternick, Edward ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

Commissioning; Electronic Brachytherapy; Intracavitary Accelerated Partial Breast Irradiation

Indexed keywords

EID: 57049123666     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v9i3.2775     Document Type: Article

References (14)

1. Faverly DR, Hendriks JH, Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer. 2001;91(4):647-659.
2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233-1241.
3. Holli K, Saaristo R, Isola J, et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer. 2001;84(2):164-169.
4. Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst. 1996;88(22):1659-1664.
5. Wazer DE, Berle L, DiPetrillo TA, et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys. 2002;53(4):889-897.
6. Shah N, Tenenholz T, Arthur DW, et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors affecting toxicity and cosmesis. Cancer. 2004;101(4):727-734.
7. Arthur DW, Vicini FA, Kuske RR, Wazer DE, Nag S. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy. 2003;2(2):124-130.
8. Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after HDR interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 2006; 64(2):489-495.
9. Arthur DA, Vicini FA: Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol. 2005;23(8):1726-1735.
10. Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys. 1995;22(2):209-234.
11. Rivard MJ, Coursey BM, DeWerd LA, et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations (AAPM Report No. 84). Med Phys. 2004;31(3):633-674.
12. Rivard MJ, Davis SD, DeWerd LA, et al. Calculated and measured brachytherapy dosimetry parameters in water for the Xoft Axxent X-ray Source: an electronic brachytherapy source. Med Phys. 2006;33(11):4020-4032.
13. Vicini F, White J, Arthur D, et al. NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. [Electronic version]. Retrieved January 29, 2008, from http://www.rtog.org/members/protocols/0413/0413.pdf.
14. Danzer J, Dudney C, Seibert R, Robinson B, Harris C, Ramsey C. Optically stimulated luminescence of aluminum oxide detectors for radiation therapy quality assurance. [Abstract]. Med Phys. 2007;34(6):2628-262.